Physician profile
Nancy E Doty
NPI 1124501044
$2,341.49
in general payments reported to CMS, 2019-2025
16 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $680 · 2023: $548 · 2024: $497 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $525.06 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $243.46 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $237.22 | 2022-2025 | |
| Pfizer INC. | $182.45 | 2022-2025 | |
| Amgen INC. | $165.07 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.31 | 2023-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $153.51 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $145.83 | 2021-2024 | Farxiga |
| Edwards Lifesciences Corporation | $142.30 | 2024-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $111.53 | 2022-2023 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $109.09 | 2022-2023 | |
| Boston Scientific Corporation | $90.20 | 2022 | |
| Atricure, INC. | $23.90 | 2023 | |
| Davol INC. | $20.51 | 2025 | Arista |
| Esperion Therapeutics, INC. | $19.27 | 2025 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $14.78 | 2023 | Evkeeza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Doty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.